CDRH Persistence Pays Off: Third-Party Review Acceptance Rates On The Rise

FDA device center efforts to reverse a third-party 510(k) review lag are succeeding, Program Coordinator Eric Rechen claimed May 24

More from Archive

More from Medtech Insight